gist - landherr
Irodalom
1. BLAY JY, BONVALOT S, CASALI P ET AL: Consensus meeting for the management of gastrointestinal
stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the
auspices of ESMO. Annals of Oncol. 2005.16:566-578.
2. NILSSON B, BÜMMING P, MEIS-KINDBLOM JM ET AL: Gastrointestinal stromal tumors: the incidence,
prevalence, clinical course, and prognostication int he preimatinib mesylate era. Cancer 2005
Feb 15:103:4:821-829.
3. ZALCBERG JR, VERWEIJ J, CASALI PG ET AL: Outcome of patients with advanced gastro-intestinal
stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400
mg. Eur J Cancer 2005.41:1751-1757
